当前位置:首页 - 行情中心 - 恩华药业(002262) - 财务分析 - 现金流量表

恩华药业

(002262)

  

流通市值:191.51亿  总市值:219.51亿
流通股本:8.84亿   总股本:10.13亿

现金流量表

报告期2026-09-302026-06-302026-03-312025-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金5,181,491,711.893,285,003,178.031,500,521,240.716,358,917,423.44
  收到的税费返还1,178,972.73407,528.33161,981.99655,090.72
  收到其他与经营活动有关的现金83,354,717.0340,186,548.1115,488,547.6873,984,119.88
  经营活动现金流入小计5,266,025,401.653,325,597,254.471,516,171,770.386,433,556,634.04
  购买商品、接受劳务支付的现金1,398,387,790.67978,264,642.45371,185,401.931,537,516,201.54
  支付给职工以及为职工支付的现金865,228,185.54517,287,737.23259,689,706.71,142,008,395.51
  支付的各项税费623,941,897.39389,493,117.75198,435,011.44750,384,346.82
  支付其他与经营活动有关的现金1,519,848,215.541,160,143,375.62529,032,021.431,925,257,933.34
  经营活动现金流出小计4,407,406,089.143,045,188,873.051,358,342,141.55,355,166,877.21
  经营活动产生的现金流量净额858,619,312.51280,408,381.42157,829,628.881,078,389,756.83
二、投资活动产生的现金流量:
  取得投资收益收到的现金35,097,564.5325,148,727.7612,205,819.7446,367,997.1
  处置固定资产、无形资产和其他长期资产收回的现金净额177,862.3292,862.329,625339,238.24
  收到的其他与投资活动有关的现金5,762,000,0003,838,000,0001,579,000,0006,817,000,000
  投资活动现金流入小计5,797,275,426.853,863,241,590.081,591,215,444.746,863,707,235.34
  购建固定资产、无形资产和其他长期资产支付的现金284,994,376.38156,909,930.7980,135,996.94437,407,150.19
  投资支付的现金8,000,000--25,158,700
  取得子公司及其他营业单位支付的现金178,374.4176,374.4-77,950
  支付其他与投资活动有关的现金6,105,000,0003,791,000,0001,716,000,0006,963,000,000
  投资活动现金流出小计6,398,172,750.783,948,086,305.191,796,135,996.947,425,643,800.19
  投资活动产生的现金流量净额-600,897,323.93-84,844,715.11-204,920,552.2-561,936,564.85
三、筹资活动产生的现金流量:
  取得借款收到的现金90,000,00090,000,00061,000,00030,000,000
  筹资活动现金流入小计90,000,00090,000,00061,000,00030,000,000
  偿还债务支付的现金120,000,00080,000,00030,000,00015,000,000
  分配股利、利润或偿付利息支付的现金406,590,179.05406,400,356.82-366,205,270.12
  支付其他与筹资活动有关的现金56,635,796.6316,632,226.698,126,739.7134,892,430.07
  筹资活动现金流出小计583,225,975.68503,032,583.5138,126,739.71416,097,700.19
  筹资活动产生的现金流量净额-493,225,975.68-413,032,583.5122,873,260.29-386,097,700.19
四、汇率变动对现金及现金等价物的影响973,277.954,545,602668,615.1-1,036,094.54
五、现金及现金等价物净增加额-234,530,709.15-212,923,315.2-23,549,047.93129,319,397.25
  加:期初现金及现金等价物余额1,342,781,677.221,342,781,677.221,342,781,677.221,213,462,279.97
  期末现金及现金等价物余额1,108,250,968.071,129,858,362.021,319,232,629.291,342,781,677.22
补充资料:
  净利润-740,305,782.6-1,054,901,758.25
  资产减值准备-39,862,089.94-39,684,627.5
  固定资产和投资性房地产折旧-78,288,500.21-146,009,287.69
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-78,288,500.21-146,009,287.69
  无形资产摊销-18,353,431.78-23,747,209
  长期待摊费用摊销-31,066,881.06-69,117,388.75
  处置固定资产、无形资产和其他长期资产的损失--102,555.04--165,788.21
  固定资产报废损失--28,375.45-835,383.26
  财务费用--3,300,357.57-3,474,946.8
  投资损失--35,914,691.23--61,159,905.52
  递延所得税--2,392,566.17--18,620,207.2
  其中:递延所得税资产减少--2,392,566.17--18,509,186.79
    递延所得税负债增加----111,020.41
  存货的减少--122,537,314.87--125,892,732.07
  经营性应收项目的减少--226,751,780.81--219,396,623.23
  经营性应付项目的增加--249,940,564.97-135,417,226.32
  其他--0.62-2,632,565.88
  现金的期末余额-1,129,858,362.02-1,342,781,677.22
  减:现金的期初余额-1,342,781,677.22-1,213,462,279.97
  现金及现金等价物的净增加额--212,923,315.2-129,319,397.25
公告日期2026-10-242026-08-182026-04-182026-04-18
审计意见(境内)标准无保留意见
TOP↑